These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6355044)

  • 1. An open study of ceftazidime in the treatment of serious bacterial infection.
    Allan SG; Glover SC; Smith CC; Hadley KM; Reid TM; Han K; Murdoch JM; Ingram PM
    J Antimicrob Chemother; 1983 Sep; 12(3):219-27. PubMed ID: 6355044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of ceftazidime in the therapy of serious infections, including those due to multiresistant organisms.
    Clumeck N; Van Laethem Y; Gordts B; Jaspar N; Butzler JP
    Antimicrob Agents Chemother; 1983 Aug; 24(2):176-80. PubMed ID: 6357068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftazidime in the therapy of serious Gram-negative bacillary infections.
    Pottage JC; Karakusis PH; Fliegelman RM; Levin S; Trenholme GM
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():223-8. PubMed ID: 6352623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftazidime in severe infections: a Swiss multicentre study.
    Francioli P; Clément M; Geroulanos S; von Graevenitz A; Luthy R; Regamey C; Stalder H; Vogt M; Waldvogel FA
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():139-46. PubMed ID: 6225761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftazidime treatment in intensive care patients.
    van Dalen R; Muytjens HL; Gimbrère JS
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():189-97. PubMed ID: 6225763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infections.
    Hoepelman AI; Kieft H; Aoun M; Kosmidis J; Strand T; Verhoef J; Gillespie SH; Riddell J; Varghese G; Meunier F
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():175-86. PubMed ID: 8150761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftazidime in clinical practice.
    Alestig K; Eilard T; Norrby R; Svensson R; Trollfors B; Brorson JE
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():111-4. PubMed ID: 6225759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftazidime--a new extended-spectrum cephalosporin.
    Gozzard DI; Geddes AM; Farrell ID; Eykyn SJ; Phillips I; Wise R; Brown RM
    Lancet; 1982 May; 1(8282):1152-6. PubMed ID: 6122940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftazidime therapy for serious infections.
    Bint AJ; Constable J; Patton KR; Constable FL
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():115-21. PubMed ID: 6352613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open study of ceftazidime in serious infections due to multiply-resistant bacteria.
    Pechère JC; Delisle R
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():181-8. PubMed ID: 6352619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of ceftazidime. Treatment of serious infection due to multiresistant Pseudomonas and other gram-negative bacteria.
    Scully BE; Neu HC
    Arch Intern Med; 1984 Jan; 144(1):57-62. PubMed ID: 6419690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftazidime in patients with Pseudomonas infections.
    Eron LJ; Park CH; Hixon DL; Goldenberg RI; Poretz DM
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():161-9. PubMed ID: 6225762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefsulodin and ceftazidime, two antipseudomonal cephalosporins.
    Smith BR
    Clin Pharm; 1984; 3(4):373-85. PubMed ID: 6380902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of ceftazidime and tobramycin in the treatment of complicated urinary tract infections.
    Cox CE
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():47-52. PubMed ID: 6352654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of ceftazidime in the treatment of bacterial infections in eighty seriously ill patients.
    Walstad RA; Hellum KB; Svarva PL; Ingram PM
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():131-7. PubMed ID: 6352614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftazidime therapy of serious bacterial infections.
    Eron LJ; Goldenberg RI; Park CH; Poretz DM
    Antimicrob Agents Chemother; 1983 Feb; 23(2):236-41. PubMed ID: 6340601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with ceftazidime in urology in Japan.
    Kawamura N
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():65-70. PubMed ID: 6352657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of cefepime versus ceftazidime in the treatment of severe infections.
    Huang CK; Chen YS; Lee SS; Lin WR; Tsai HC; Lin HH; Wann SR; Chen JY; Yen MY; Liu YC
    J Microbiol Immunol Infect; 2002 Sep; 35(3):159-67. PubMed ID: 12380788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftazidime therapy of infections caused by Enterobacteriaceae and Pseudomonas aeruginosa.
    Maslow MJ; Rosenberg A; Pollock AA; Press RA; Silverman D; El-Sadr W; Richmond AS; Simberkoff MS; Rahal JJ
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():213-7. PubMed ID: 6413486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftazidime as a single agent in the treatment of severe Pseudomonas aeruginosa infections.
    Clumeck N; Gordts B; Dab I; Jaspar N; Van Laethem Y; Butzler JP
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():207-11. PubMed ID: 6352620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.